ArticleAbschluss Der Revision Des HeilmittelgesetzesIn der Frühjahrsession 2016 wurde das revidierte Heilmittelgesetz von beiden Räten nach einer Einigungskonferenz angenommen.SwitzerlandFood, Drugs, Healthcare, Life SciencesBär & Karrer Ltd.
ArticleNew Regulations Regarding Drug PricingIn its decision of 14 December 2015, the Swiss Federal Supreme Court had confirmed that the practice of the Federal Office of Public Health (FOPH) which, in the course of the regular triennial review, determines the prices of drugs...SwitzerlandFood, Drugs, Healthcare, Life SciencesBär & Karrer Ltd.
ArticleThe Revision Of The Therapeutic Products Act Has Been AdoptedThe National Council and the Council of States have adopted the revised Therapeutic Products Act during the federal parliament's spring session of 2016. SwitzerlandFood, Drugs, Healthcare, Life SciencesBär & Karrer Ltd.
ArticleImplementation Of Several Parts Of The Revised TPA And Pata As Well As Of The Therapeutic-Products-Ordinance-Package IV On 1 January 2019On 21 September 2019, the Federal Council decided to implement several parts of the amendments adopted in the spring session 2016 regarding the legislation ...SwitzerlandFood, Drugs, Healthcare, Life SciencesBär & Karrer Ltd.
ArticleReproductive Medicine - Permissibility And Limits In SwitzerlandOn 1 September 2017, the revised law on reproductive medicine and the revised reproductive medicine ordinance came into force in SwitzerlandSwitzerlandFood, Drugs, Healthcare, Life SciencesMLL Meyerlustenberger Lachenal Froriep Ltd
ArticleA Turning Point For Fiduciary Accountability: PBM-Owned Rebate Aggregators In The SpotlightIn 2025, federal scrutiny of Pharmacy Benefit Managers (PBMs) has reached a level not seen before. What was once tolerated as opaque and self-serving practices is now the subject of a coordinated...SwitzerlandAccounting and AuditBuchanan Ingersoll & Rooney
ArticleConsultation Opened On Amendments To Pharmaceutical PricingSwitzerland is moving ahead with the implementation of the Cost Containment Package 2: On 18 February 2026, the Federal Council opened the consultation on a third set of significant revisions...SwitzerlandFood, Drugs, Healthcare, Life SciencesBär & Karrer Ltd.
ArticlePartial Revision Of The Swiss Therapeutic Products Act – Package 3b (HMG 3b)Bär & Karrer, a Swiss law firm, provides comprehensive legal and business solutions. Contact their Zurich office for expert assistance with legal advice, business inquiries, and professional services tailored to your needs. SwitzerlandFood, Drugs, Healthcare, Life SciencesBär & Karrer Ltd.
ArticleGrundsatzurteil Und Verordnungsrevisionen Betreffend Überprüfung Von ArzneimittelpreisenIn einem Grundsatzentscheid vom 30. April 2015 hat das Bundesverwaltungsgericht entschieden, die bald fünfjährige Praxis des Bundesamts für Gesundheit (BAG)...SwitzerlandFood, Drugs, Healthcare, Life SciencesBär & Karrer Ltd.
ArticleRegulatory Framework For CBD Products In SwitzerlandAccording to the current regulatory set-up in Switzerland, it is permissible to sell and purchase cannabis products, as long as the THC level remains below 1%. SwitzerlandFood, Drugs, Healthcare, Life SciencesLoyens & Loeff
ArticleDigital Agriculture: How Patents Help To Ensure Sustainable Food SecurityThe European Patent Office (EPO) has launched a series of initiatives to measure and encourage innovation in digital agriculture across the EU.European UnionIntellectual PropertyNovagraaf Netherlands BV
ArticleNeue Regeln Für Die Festsetzung Der MedikamentenpreiseDas Bundesgericht hatte mit Urteil vom 14. Dezember 2015 bestätigt, dass die Praxis des Bundesamts für Gesundheit (BAG), die Preise von Arzneimitteln der Spezialitätenliste (SL) bei der ordentlichen Dreijahresüberprüfung grundsätzlich nur im Vergleich mit den Auslandpreisen zu überprüfen, gegen das Krankenversicherungsgesetz (KVG) verstösst. SwitzerlandFood, Drugs, Healthcare, Life SciencesBär & Karrer Ltd.
ArticleRevision Des Heilmittelgesetzes (HMG): Erhöhte Medikationssicherheit Und Arzneimittel Für Neuartige TherapienAm 3. September 2025 hat der Bundesrat die Botschaft zur Teilrevision des HMG zuhanden des Parlaments verabschiedet.SwitzerlandFood, Drugs, Healthcare, Life SciencesBär & Karrer Ltd.
ArticleFreispruch für das Doping!Die heutige Dopingpolitik mit ihrer angeblichen Sorge um die Gesundheitsgefährdung von Spitzensportlern ist von Widersprüchen geprägt und möglicherweise verfassungswidrig. WorldwideMedia, Telecoms, IT, EntertainmentRihm Attorneys
ArticleLife Sciences 2025Swiss healthcare regulation is spread over various statutes, ordinances and guidelines, including self-regulatory instruments such as best practice codes and references to international provisions.SwitzerlandFood, Drugs, Healthcare, Life SciencesBär & Karrer Ltd.
ArticleLife Sciences 2025According to Swiss nomenclature, the term therapeutic products covers medicinal products as well as medical devices.SwitzerlandFood, Drugs, Healthcare, Life SciencesBär & Karrer Ltd.
ArticleLife Sciences In Switzerland: Legal And Regulatory OverviewMedicinal products are products of chemical or biological origin which are intended or claimed to have a medicinal effect on the human organism, in particular in the diagnosis, prevention or treatment of diseases...SwitzerlandFood, Drugs, Healthcare, Life SciencesBär & Karrer Ltd.
ArticleLife Sciences 2024Swiss healthcare regulation is spread over various statutes, ordinances and guidelines, including self-regulatory instruments such as best practice codes and references to international provisions.SwitzerlandFood, Drugs, Healthcare, Life SciencesBär & Karrer Ltd.